SARS-CoV-2 Spike evolution influences GBP and IFITM sensitivity
Mesner, D.; Reuschl, A.-K.; Whelan, M. V. X.; Bronzovich, T.; Haider, T.; Thorne, L. G.; Towers, G. J.; Jolly, C.
Show abstract
SARS-CoV-2 spike requires proteolytic processing for viral entry. The presence of a polybasic furin-cleavage site (FCS) in spike, and evolution towards an optimised FCS by dominant variants of concern (VOCs), are linked to enhanced infectivity and transmission. Here we show that interferon-inducible antiviral restriction factors Guanylate binding proteins (GBP) 2 and 5 interfere with furin-mediated cleavage of SARS-CoV-2 spike and inhibit the infectivity of early-lineage Wuhan-Hu-1, while VOCs Alpha and Delta have evolved to escape restriction. Strikingly, we find Omicron is unique amongst VOCs, being restricted by GBP2/5, and also IFITM1, 2 and 3. Replacing the spike S2 domain in Omicron with Delta shows S2 is the determinant of entry route and IFITM sensitivity. We conclude that VOC evolution under different selective pressures has influenced sensitivity to spike-targeting restriction factors, with Omicron selecting spike changes that not only mediate antibody escape, and altered tropism, but also sensitivity to innate immunity.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- TRIM25 and ZAP target the Ebola virus ribonucleoprotein complex to mediate interferon-induced restriction 96%
- Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion 96%
- Phosphatidylserine Receptors Enhance SARS-CoV-2 Infection: AXL as a Therapeutic Target for COVID-19 96%
Similar papers in this journal
Similar papers in this journal
- The Relative Binding Position of Nck and Grb2 Adaptors Dramatically Impacts Actin-Based Motility of Vaccinia Virus 97%
- Antiviral function and viral antagonism of the rapidly evolving dynein activating adapter NINL 97%
- The interferon-inducible GTPase MxB promotes capsid disassembly and genome release of herpesviruses 96%